Fidelity Investments’s Cambria Cannabis ETF TOKE Stock Holding History

Fidelity Investments’s Portfolio TOKE Stock Details TOKE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	5022
2021 Q2	$0	Buy	+1	New	+$18	﹤0.01%	4871

Other funds holding TOKE

TAP Consulting Kirkwood, Missouri $489M AUM 8.88% 1-Year Est. Return

Cambridge Advisors Omaha, Nebraska $582M AUM 19.14% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BWP

Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

GWS

Glassman Wealth Services Vienna, Virginia $736M AUM 17.99% 1-Year Est. Return

Fidelity Investments's TOKE Position: Q3 2021 in Review

Fidelity Investments sold out of Cambria Cannabis ETF (TOKE) in Q3 2021, closing a stake of 1 share.

Fidelity Investments first reported a position in TOKE in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 25 funds tracked by Wall St. Rank hold TOKE as of Q3 2021.

Fidelity Investments reported no remaining Cambria Cannabis ETF position as of Q3 2021 after selling out during the quarter.
Fidelity Investments sold 1 Cambria Cannabis ETF share in Q3 2021.
Fidelity Investments first reported a position in Cambria Cannabis ETF in Q2 2021 and held it in 1 quarter.
Fidelity Investments's Cambria Cannabis ETF position peaked at $0 in Q2 2021.
25 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.